All In Biotech

Drug Trial Radar · NCT07599410

A Research Study to Investigate the Efficacy and Safety of HRS9531 Tablets in Participants With Type 2 Diabetes Mellitus

A Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group Phase 2 Study to Evaluate the Efficacy and Safety of HRS9531 Tablets in Participants With Type 2 Diabetes Mellitus.

Last checked: Nov 19, 2026Latest source record: Jul 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 240 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

240

Planned (sponsor's estimate)

Start

Jul 14, 2026

Primary completion

May 2027

Study completion Jul 2027

Sponsor

Sponsor type
Industry
First posted
May 20, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The aim of the trial is to investigate the efficacy and safety of HRS9531 tablets versus placebo in participants with type 2 diabetes mellitus who failed to achieve adequate glycemic control on lifestyle intervention alone or on a stable dose of metformin. This study will last 20 weeks.

Conditions

  • T2DM

Interventions

  • HRS9531 TabletDrug

    HRS9531 Tablet dose 1

  • HRS9531 TabletDrug

    HRS9531 Tablet dose 2

  • HRS9531 TabletDrug

    HRS9531 Tablet dose 3

  • HRS9531 TabletDrug

    HRS9531 Tablet dose 4

  • HRS9531 TabletDrug

    HRS9531 Tablet dose 5

  • HRS9531 Tablet placeboDrug

    HRS9531 Tablet placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in glycated hemoglobin (HbA1c) relative to baselineTime frame: Week 20.

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Beijing Chaoyang Hospital, Capital Medical University

    Beijing, Beijing Municipality, China · Recruiting

  • Qilu Hospital of Shandong University

    Jinan, Shandong, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.